
OCTAGON CAPITAL ADVISORS LP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | GOSS | 13.92M | $43.14M |
![]() | PALI | 9.57M | $22.48M |
![]() | TSHA | 8.86M | $48.73M |
![]() | TRVI | 2.81M | $35.24M |
![]() | OCUL | 2.62M | $31.85M |
![]() | ALMS | 2.53M | $24.70M |
![]() | DNTH | 2.42M | $99.59M |
![]() | COGT | 2.35M | $83.47M |
![]() | MNMD | 2.23M | $29.86M |
![]() | AVBP | 1.97M | $39.66M |
![]() | DTIL | 1.92M | $7.98M |
![]() | LXEO | 1.73M | $17.13M |
![]() | BIOA | 1.60M | $21.14M |
![]() | KALV | 1.27M | $20.56M |
![]() | BBOT | 1.04M | $13.06M |
![]() | UNCY | 1.00M | $5.77M |
![]() | ABVX | 756K | $101.95M |
![]() | CNTA | 750K | $18.76M |
![]() | PEPG | 700K | $4.56M |
![]() | PHVS | 671K | $18.63M |

Gossamer Bio, Inc.
GOSS
Shares Held
13.92M
Value
$43.14M

Palisade Bio, Inc.
PALI
Shares Held
9.57M
Value
$22.48M

Taysha Gene Therapies, Inc.
TSHA
Shares Held
8.86M
Value
$48.73M

Trevi Therapeutics, Inc.
TRVI
Shares Held
2.81M
Value
$35.24M

Ocular Therapeutix, Inc.
OCUL
Shares Held
2.62M
Value
$31.85M

Alumis Inc. Common Stock
ALMS
Shares Held
2.53M
Value
$24.70M

Dianthus Therapeutics, Inc.
DNTH
Shares Held
2.42M
Value
$99.59M

Cogent Biosciences, Inc.
COGT
Shares Held
2.35M
Value
$83.47M

Mind Medicine (MindMed) Inc.
MNMD
Shares Held
2.23M
Value
$29.86M

ArriVent BioPharma, Inc. Common Stock
AVBP
Shares Held
1.97M
Value
$39.66M

Precision BioSciences, Inc.
DTIL
Shares Held
1.92M
Value
$7.98M

Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
1.73M
Value
$17.13M

BioAge Labs, Inc.
BIOA
Shares Held
1.60M
Value
$21.14M

KalVista Pharmaceuticals, Inc.
KALV
Shares Held
1.27M
Value
$20.56M

BridgeBio Oncology Therapeutics Inc.
BBOT
Shares Held
1.04M
Value
$13.06M

Unicycive Therapeutics, Inc.
UNCY
Shares Held
1.00M
Value
$5.77M

Abivax S.A.
ABVX
Shares Held
756K
Value
$101.95M

Centessa Pharmaceuticals plc
CNTA
Shares Held
750K
Value
$18.76M

PepGen Inc.
PEPG
Shares Held
700K
Value
$4.56M

Pharvaris N.V.
PHVS
Shares Held
671K
Value
$18.63M
